The global rise in neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease has intensified the search for effective prevention strategies. Recent research from Yonsei University College of Medicine in Seoul, South Korea, offers promising evidence that a class of type 2 diabetes drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors may significantly reduce the… Continue reading Diabetes Drug Lowers Dementia Risk
Category: Research Updates
Understanding Parkinson’s Psychosis
Parkinson’s disease is perhaps best known for its hallmark motor symptoms like tremor and rigidity. However, more than half of individuals with this neurodegenerative disorder will ultimately experience psychosis, a nonmotor symptom that can be particularly unsettling and distressing for both patients and their caregivers. Psychosis in Parkinson’s can manifest as hallucinations, delusions, or behavioral… Continue reading Understanding Parkinson’s Psychosis
Understanding the Types of Parkinson’s and Parkinsonism
Navigating the complexities of Parkinson’s disease (PD) and its various forms can be challenging. This blog post delves into different types of Parkinsonism, highlighting the importance of accurate diagnosis and personalized treatment strategies. Parkinsonism encompasses several conditions with motor symptoms like bradykinesia (slowed movements), tremors, balance loss, and stiffness. Understanding these distinctions is vital for… Continue reading Understanding the Types of Parkinson’s and Parkinsonism
Coffee and Parkinson’s: Can it Help?
When we think about managing Parkinson’s disease (PD), coffee isn’t the first thing that comes to mind. Yet, over the years, research has consistently suggested that regular coffee consumption may provide benefits for those at risk of Parkinson’s or even those already diagnosed. Let’s take a deep dive into how coffee—especially its key compounds like… Continue reading Coffee and Parkinson’s: Can it Help?
Title: Cognitive Decline in Parkinson’s: Early Detection and Management
Parkinson’s disease (PD) is not just a movement disorder; cognitive impairment is also a significant feature. Cognitive issues, ranging from mild cognitive impairment (MCI) to full-blown dementia, can affect people with PD even early in their diagnosis. This blog post will delve into the complexities of cognitive impairment in Parkinson’s, discussing its types, prevalence, risk… Continue reading Title: Cognitive Decline in Parkinson’s: Early Detection and Management